Titlebook: Immunosuppression under Trial; Proceedings of the 3 P. Cochat,J. Traeger,M. Derchavane Conference proceedings 1999 Springer Science+Busines

Paradox

https://doi.org/10.1007/978-94-011-4643-2cancer; clinical trial; immunosuppression; kidney; transplantation

假裝是我

PTCA635

Cardiovascular complications after renal transplantation The survival advantage conferred by transplantation is well illustrated by the studies of Port et al. [4] and Bonal et al. [5]. The relative mortality of graft recipients beyond the first month after transplantation was substantially lower, particularly in diabetic patients [4] and high risk elderl

Atheroma

嚴(yán)厲譴責(zé)

abject